Phase II trial of the novel combination, decitabine, venetoclax, and ponatinib achieved bone marrow remission in 80% of patients with advanced CML...

Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and...

The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from the Leukemia and...

The post

New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...

A chronic inflammatory disorder of the gastrointestinal (GI) tract, inflammatory bowel disease (IBD) includes Crohn's disease (CD) and...

RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.

Advanced treatments like CAR-T cell therapy and bone marrow transplants are significantly improving outcomes for lymphoma patients, experts highlight...

Graeme felt it was 'the end of the line' for him after his previous treatments failed when he was offered the new 'lifeline' drug.

Graeme felt it was 'the end of the line' for him after his previous treatments failed when he was offered the new 'lifeline' drug.